Conditional glucocorticoid receptor expression in the heart induces atrio‐ventricular block
- 21 May 2007
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 21 (12) , 3133-3141
- https://doi.org/10.1096/fj.07-8357com
Abstract
Corticosteroid hormones (aldosterone and glucocorticoids) and their receptors are now recognized as major modulators of cardiovascular pathophysiology, but their specific roles remain elusive. Glucocorticoid hormones (GCs), which are widely used to treat acute and chronic diseases, often have adverse cardiovascular effects such as heart failure, hypertension, atherosclerosis, or metabolic alterations. The direct effects of GC on the heart are difficult to evaluate, as changes in plasma GC concentrations have multiple consequences due to the ubiquitous expression of the glucocorticoid receptor (GR), resulting in secondary effects on cardiac function. We evaluated the effects of GR on the heart in a conditional mouse model in which the GR was overexpressed solely in cardiomyocytes. The transgenic mice displayed electrocardiogram (ECG) abnormalities: a long PQ interval, increased QRS and QTc duration as well as chronic atrio-ventricular block, without cardiac hypertrophy or fibrosis. The ECG alterations were reversible on GR expression shutoff. Isolated ventricular cardiomyocytes showed major ion channel remodeling, with decreases in INa, Ito, and IKslow activity and changes in cell calcium homeostasis (increase in Cal, in Ca2+ transients and in sarcoplasmic reticulum Ca2+ load). This phenotype differs from that observed in mice overexpressing the mineralocorticoid receptor in the heart, which displayed ventricular arrhythmia. Our mouse model highlights novel effects of GR activation in the heart indicating that GR has direct and specific cardiac effects in the mouse.—Sainte-Marie, Y., Cat, A. N. D., Perrier, R., Mangin, L., Soukaseum, C., Peuchmaur, M., Tronche, F., Farman, N., Escoubet, B., Benitah, J-P., Jaisser, F. Conditional glucocorticoid receptor expression in the heart induces atrio-ventricular block.Keywords
Funding Information
- Fondation de France
This publication has 36 references indexed in Scilit:
- Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular DiseaseAnnals of Internal Medicine, 2004
- Dexamethasone treatment improves sarcoplasmic reticulum function and contractile performance in aged myocardiumMolecular and Cellular Biochemistry, 2004
- Does altered glucocorticoid homeostasis increase cardiovascular risk?Cardiovascular Research, 2004
- Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control studyHeart, 2004
- Dexamethasone-induced Hypertrophy in Rat Neonatal Cardiac Myocytes Involves an Elevated L-type Ca2+CurrentJournal of Molecular and Cellular Cardiology, 1999
- Glucocorticoid Regulation of Cardiac K + Currents and L-Type Ca 2+ Current in Neonatal MiceCirculation Research, 1999
- Cardiovascular effects of dexamethasone in the preterm infant.Archives of Disease in Childhood: Fetal & Neonatal, 1994
- Hypertrophic Cardiomyopathy Associated with Dexamethasone Therapy for Chronic Lung Disease in Preterm InfantsAmerican Journal of Perinatology, 1993
- Inotropic effects of dexamethasone in mammalian heart muscleEuropean Journal of Pharmacology, 1971
- Influence of corticosteroids on mechanical performance of isolated rat papillary musclesAmerican Journal of Physiology-Legacy Content, 1968